Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

ABSTRACT:

SUBMITTER: Soumerai JD 

PROVIDER: S-EPMC9837428 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature